| Zavante Plans FDA Filing After Antibiotic Hits Clinical Trial Goals | Frank Vinluan | 04/06/17 | San Diego |
| With Fresh Pneumonia Data, Paratek To Seek 2018 Antibiotic Approval | Ben Fidler | 04/03/17 | Boston |
| Cempra Soars on Drug’s Potential to Treat MRSA, Other Infections | Frank Vinluan | 02/24/17 | Raleigh Durham |
| Bio Roundup: Mylan Grilled, Duchenne Kids Thrilled, Zuck-Chan & More | Alex Lash | 09/23/16 | National |
| Paratek Shares Climb After Antibiotic Clears First Phase 3 Hurdle | Ben Fidler | 06/16/16 | Boston |
| Vedanta Nabs $50M To Expand Microbiome Into Immune-Boosting Therapies | Ben Fidler | 06/06/16 | Boston |
| Spero Rolls up More Antibiotics With Vertex Deal | Ben Fidler | 05/25/16 | Boston |
| East Coast Biotech Roundup: PfizerGan, Nimbus, Intercept, Tesaro & More | Ben Fidler | 04/08/16 | Boston |
| Warp Drive, Surface, Bamboo Cut Deals on Eve of J.P. Morgan | Ben Fidler | 01/11/16 | Boston |
| Former Cubist CEO Mike Bonney Joins Third Rock Ventures | Alex Lash | 01/07/16 | Boston |
| To Fight “Superbugs,” Roche Shells Out $190M For Bay Area’s GeneWEAVE | Ben Fidler | 08/13/15 | San Francisco |
| East Coast Biotech Roundup: Vertex, Biogen, Sarepta, Juno, & More | David Holley | 07/06/15 | Boston |
| East Coast Biotech Roundup: XTuit, Spero, Unum, RNAi Feud & More | Ben Fidler | 06/12/15 | Boston |
| With $30M, Spero Broadens Fight Against Drug-Resistant Bugs | Ben Fidler | 06/08/15 | Boston |
| Now Biotech-Only, Atlas Reloads With $280M Fund For New Startups | Ben Fidler | 04/17/15 | Boston |
| Admetsys Wins Top Prize at SXSW Hatch Pitch, Astroprint and Plum Follow | David Holley | 03/16/15 | Texas |
| Antibiotics Startup Gets $22M From Roche, Others, For New “Macrolides” | Ben Fidler | 03/04/15 | Boston |
| “21st Century Cures” By Year’s End? Its Backers Want More Ideas | Ben Fidler | 02/09/15 | National |
| Independent No More: Cubist Sold to Merck for $9.5B | Ben Fidler | 12/08/14 | Boston |
| Austin Biotech Savara Nets $10M to Develop Cystic Fibrosis Drug | Angela Shah | 10/06/14 | Texas |
| With FDA Nod, T2 Bio’s Sepsis Test Heads to Commercial Proving Ground | Ben Fidler | 09/23/14 | Boston |
| Cempra Milestone Highlights Experimental Antibiotic’s Potential | Frank Vinluan | 09/09/14 | Raleigh Durham |
| Synlogic Gets $30M From Atlas, NEA to Turn Smart Bugs Into Drugs | Ben Fidler | 07/22/14 | Boston |
| San Diego Biotech Raises Over $30M to Fight Deadly Fungal Infections | Bruce V. Bigelow | 06/25/14 | San Diego |
| Otonomy Raises $49M to Advance 3 Drugs for Treating Ear Diseases | Bruce V. Bigelow | 04/30/14 | San Diego |
| Spero Emerges With $3M, Backing From Roche, & Plans to Disarm Bugs | Ben Fidler | 04/09/14 | Boston |
| Enanta, No Longer Obscure, Seeks Slice of Big Hepatitis C Market | Ben Fidler | 01/24/14 | Boston |
| Space Flight Launched Today Includes CU Studies of Antibiotics, Ants | Michael Davidson | 01/09/14 | Boulder/Denver |
| San Diego Life Sciences Roundup: Rempex, Pfenex, Halozyme & More | Bruce V. Bigelow | 12/19/13 | San Diego |
| Cubist Shares Climb As Antibiotic Scores in Phase 3 Again | Ben Fidler | 12/16/13 | Boston |
